Ingunn Munch Lindvig
General Counsel bei BIOINVENT INTERNATIONAL AB
Profil
Ingunn Munch Lindvig is currently the Senior Vice President-Regulatory Affairs at BioInvent International AB since 2023.
Previously, she worked as the Head-Regulatory Affairs at Nordic Nanovector ASA and as the Vice President & Head-Regulatory Affairs at Circio Holding ASA. Dr. Lindvig holds a doctorate degree from the University of Oslo.
Aktive Positionen von Ingunn Munch Lindvig
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | General Counsel | 12.06.2023 |
Ehemalige bekannte Positionen von Ingunn Munch Lindvig
| Unternehmen | Position | Ende |
|---|---|---|
| THOR MEDICAL | General Counsel | - |
| CIRCIO HOLDING ASA | General Counsel | - |
Ausbildung von Ingunn Munch Lindvig
| University of Oslo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CIRCIO HOLDING ASA | Health Technology |
| BIOINVENT INTERNATIONAL AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
